Cargando…
Current Trends in the Duration of Anticoagulant Therapy for Venous Thromboembolism: A Systematic Review
Anticoagulation therapy is the first line and drug of choice for both the treatment and prophylaxis of venous thromboembolism (deep vein thrombosis and/or pulmonary embolism). Anticoagulation drugs, ranging from different preparations of heparin, warfarin, and newer direct oral drugs such as rivarox...
Autores principales: | Alexander, Peter, Visagan, Shakthi, Issa, Reem, Gorantla, Vasavi Rakesh, Thomas, Sneha E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608253/ https://www.ncbi.nlm.nih.gov/pubmed/34853735 http://dx.doi.org/10.7759/cureus.18992 |
Ejemplares similares
-
Obstructive Sleep Apnea as a Risk Factor for Venous Thromboembolism: A Systematic Review
por: Raj, Rhea, et al.
Publicado: (2022) -
Antiplatelets and Vascular Dementia: A Systematic Review
por: Alexander, Peter, et al.
Publicado: (2022) -
Anticoagulants and Dementia: A Systematic Review
por: Kalloo, Amy E, et al.
Publicado: (2023) -
Carotid Artery Calcification: What We Know So Far
por: Ahmed, Madeeha, et al.
Publicado: (2021) -
Non-alcoholic Fatty Liver Disease and Gallstones: A Systematic Review
por: Slouha, Ethan, et al.
Publicado: (2023)